Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.25 -0.05 (-0.68%) Market Cap: 2.31 Bil Enterprise Value: 4.84 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

Q3 2023 Amneal Pharmaceuticals Inc Earnings Call Transcript

Nov 07, 2023 / 01:30PM GMT
Release Date Price: €3.88 (-1.52%)
Operator

Good morning, and welcome to the Amneal Quarter 2023 Earnings Call. I will now turn the call over to Amneal Head of Investor Relations, Anthony DiMeo.

Anthony DiMeo
Amneal Pharmaceuticals, Inc. - Senior Director of IR

Good morning, and thank you for joining Amneal Pharmaceuticals Third Quarter 2023 Earnings Call. Today, we issued a press release reporting our Q3 results. We announced certain unaudited preliminary results for Q3 on October 23. Our earnings press release and presentation are available at amneal.com. Certain statements made on this call regarding matters that are not historical facts, including, but not limited to, management's outlook or predictions are forward-looking statements that are based solely on information that is now available to us. Please see the section entitled Cautionary Statements on Forward-Looking Statements in the earnings presentation and our SEC filings for a discussion of factors that may impact our future performance. We also discuss non-GAAP measures. Information on our use of these measures and reconciliations to U.S.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot